Global Rabies Antiserum Market Is Estimated To Witness High Growth Owing To Increasing Demand For Preventive Measures Against Rabies
![]() |
Rabies Antiserum Market |
The global Rabies Antiserum Market is estimated to be valued at US$ 1.20 billion in 2022 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Rabies antiserum is a preventive measure against the deadly rabies virus. It is
used as a passive immunization therapy to provide immediate protection to
individuals who have been exposed to the virus. Rabies antiserum is derived
from the blood of animals immunized with rabies vaccines or hyperimmune serum.
It contains antibodies that neutralize the rabies virus and prevent its spread
within the body.
The need for rabies antiserum arises due to the high fatality rate associated
with rabies infections. Rabies is a zoonotic viral disease that is transmitted
from animals to humans through bites or scratches. Once symptoms appear, it is
almost always fatal. Therefore, immediate administration of rabies antiserum is
crucial in preventing the onset of the disease and saving lives.
Market Key Trends:
One key trend in the global Rabies Antiserum Market is the increasing awareness
about rabies prevention and the need for timely treatment. Governments and
healthcare organizations are actively promoting vaccination campaigns and
educating people about the importance of seeking medical attention after an
animal bite. This awareness has led to a higher demand for rabies antiserum as
individuals are taking proactive measures to prevent the onset of the disease.
For example, in countries like India where rabies is endemic, awareness
campaigns are being conducted frequently to educate people in rural areas where
access to healthcare facilities is limited. These campaigns focus on promoting
timely vaccination, including the administration of rabies antiserum, and
reaching out to healthcare providers in remote areas.
PEST Analysis:
Political: Governments play a crucial role in promoting rabies prevention by
implementing vaccination programs, regulating the production and distribution
of rabies antiserum, and ensuring its availability in healthcare facilities.
Political stability and support are essential for a successful rabies
prevention strategy.
Economic: The economic factor comes into play when determining the
affordability and accessibility of rabies antiserum. Developing countries with
limited healthcare budgets may face challenges in procuring and distributing
antiserum. Subsidies and collaborations with international organizations can
help make the treatment accessible to all.
Social: The social factor encompasses public awareness, education, and cultural
beliefs surrounding rabies prevention. Socio-economic factors, urbanization,
and population growth also influence the demand for rabies antiserum. Education
campaigns need to address these social aspects to effectively reach and impact
the target audience.
Technological: Technological advancements in the production and purification of
rabies antiserum have contributed to its greater availability and improved
efficacy. Research is focused on developing more affordable and efficient
manufacturing processes to meet the growing demand.
Key Takeaways:
Paragraph 1: The global Rabies
Antiserum Market is expected to witness high growth, exhibiting a CAGR of 3.3% over the forecast period,
due to increasing awareness about rabies prevention and the need for immediate
treatment after exposure to the virus. Governments and healthcare organizations
are actively promoting vaccination campaigns and educating people about the
importance of timely intervention.
Paragraph 2: In terms of regional analysis, Asia Pacific is expected to be the
fastest-growing and dominating region in the global Rabies Antiserum Market.
This can be attributed to the high incidence of rabies cases in countries like
India, China, and Southeast Asian nations. Furthermore, proactive initiatives
by governments and rising healthcare expenditure in the region are fueling
market growth.
Paragraph 3: Key players operating in the global Rabies Antiserum Market are
CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd.,
Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, MassBiologics, Serum
Institute of India Ltd., Green Cross Corp., Haffkine Bio-Pharmaceutical
Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG
(China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd.,
and Beijing Tiantan Biological Products Co. Ltd. These players focus on product
development, collaborations, and geographic expansion to strengthen their
market presence and meet the growing demand for rabies antiserum.
In conclusion, the global Rabies Antiserum Market is witnessing significant
growth due to increasing awareness about rabies prevention and the importance
of immediate treatment. Governments, healthcare organizations, and key players
in the market are playing a crucial role in promoting vaccination campaigns and
ensuring the availability of rabies antiserum. The market is expected to
continue its upward trajectory, especially in Asia Pacific, driven by rising
incidences of rabies cases and proactive measures by governments.
Comments
Post a Comment